Melissa Assel

Jan 25, 2024 | europeanurology.com | Andrew J. Vickers |Melissa Assel |Matthew R. Cooperberg

To read this article in full you will need to make a paymentSubscribe to European UrologyReferencesThree things about Gleason grading that just about everyone believes but that are almost certainly wrong. Urology. 143: 16-19Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?. Am J Surg Pathol. 36: 1346-1352Clinical usefulness of total length of Gleason pattern 4 on biopsy in men with grade group 2 prostate cancer. J Urol.

Jan 25, 2024 | europeanurology.com | Andrew J. Vickers |Melissa Assel |Matthew R. Cooperberg

Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study

Jan 11, 2024 | europeanurology.com | Jim C. Hu |Melissa Assel |Andrew J. Vickers |Andrew Cohen

Abstract The transrectal biopsy approach is traditionally used to detect prostate cancer. An alternative transperineal approach is historically performed under general anesthesia, but recent advances enable transperineal biopsy to be performed under local anesthesia. We sought to compare infectious complications of transperineal biopsy without antibiotic prophylaxis versus transrectal biopsy with targeted prophylaxis.